Group | |||||
---|---|---|---|---|---|
Characteristic | Overall, N = 135 | Group 0, N = 20 | Group 1, N = 72 | Group 2, N = 43 | p-value |
Age | 0.446 | ||||
< 60 | 34 (25.2%) | 5 (25.0%) | 21 (29.2%) | 8 (18.6%) | |
≥ 60 | 101 (74.8%) | 15 (75.0%) | 51 (70.8%) | 35 (81.4%) | |
Gender | 0.060 | ||||
Female | 94 (69.6%) | 18 (90.0%) | 50 (69.4%) | 26 (60.5%) | |
Male | 41 (30.4%) | 2 (10.0%) | 22 (30.6%) | 17 (39.5%) | |
T stage | 0.778 | ||||
T1/T2 | 117 (86.7%) | 18 (90.0%) | 63 (87.5%) | 36 (83.7%) | |
T3/T4 | 18 (13.3%) | 2 (10.0%) | 9 (12.5%) | 7 (16.3%) | |
N status | 0.845 | ||||
N0 | 105 (77.8%) | 16 (80.0%) | 57 (79.2%) | 32 (74.4%) | |
N1/N2 | 30 (22.2%) | 4 (20.0%) | 15 (20.8%) | 11 (25.6%) | |
TNM stage | 0.781 | ||||
I-II | 96 (71.1%) | 14 (70.0%) | 53 (73.6%) | 29 (67.4%) | |
III-IV | 39 (28.9%) | 6 (30.0%) | 19 (26.4%) | 14 (32.6%) | |
Differentiation | 0.001 | ||||
Well or moderately | 68 (50.4%) | 17 (85.0%) | 36 (50.0%) | 15 (34.9%) | |
Poorly or undifferentiated | 67 (49.6%) | 3 (15.0%) | 36 (50.0%) | 28 (65.1%) | |
Vascular invasion | 0.580 | ||||
Negative | 108 (80.0%) | 17 (85.0%) | 59 (81.9%) | 32 (74.4%) | |
Positive | 27 (20.0%) | 3 (15.0%) | 13 (18.1%) | 11 (25.6%) | |
Perineural invasion | 0.429 | ||||
Negative | 89 (65.9%) | 15 (75.0%) | 44 (61.1%) | 30 (69.8%) | |
Positive | 46 (34.1%) | 5 (25.0%) | 28 (38.9%) | 13 (30.2%) |